Literature DB >> 17235496

Lung cancer mortality and body mass index in a Japanese cohort: findings from the Japan Collaborative Cohort Study (JACC Study).

Takaaki Kondo1, Yoko Hori, Hiroshi Yatsuya, Koji Tamakoshi, Hideaki Toyoshima, Yoshikazu Nishino, Nao Seki, Yoshinori Ito, Koji Suzuki, Kotaro Ozasa, Yoshiyuki Watanabe, Masahiko Ando, Kenji Wakai, Akiko Tamakoshi.   

Abstract

OBJECTIVE: To determine the relationship of body mass index (BMI) and BMI changes during adulthood to lung cancer mortality in a large-sized Japanese cohort.
METHODS: We followed 29,350 men for a maximum of 11 years in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study), which was initiated from 1988 to 1990. Complementary log-log modeling was employed with age, smoking status, and family history of lung cancer as covariates. Anthropometric measurements used were BMI at baseline, BMI around age 20, and adulthood BMI loss defined between the two measurements. Independent effects of these three measurements on lung cancer mortality were evaluated by applying the method of generalized estimation equations to the model for adjustment of intra-individual correlation.
RESULTS: Never smokers showed that high BMI both at baseline and around age 20 significantly predict lung cancer mortality (P < 0.05). Adulthood BMI loss significantly (P < 0.05) elevated the risk for lung cancer mortality among current smokers, implying their enhanced vulnerability to lung cancer risk among smokers.
CONCLUSIONS: The risk for lung cancer mortality is elevated by a mechanism related to smoking-induced weight loss during adulthood.

Entities:  

Mesh:

Year:  2007        PMID: 17235496     DOI: 10.1007/s10552-006-0069-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  5 in total

1.  A survival analysis using physique-adjusted tumor size of non-small cell lung cancer.

Authors:  Naoki Ozeki; Takayuki Fukui; Koji Kawaguchi; Shota Nakamura; Shuhei Hakiri; Taketo Kato; Akihiro Hirakawa; Kohei Yokoi
Journal:  Int J Clin Oncol       Date:  2017-11-29       Impact factor: 3.402

2.  Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.

Authors:  J Wang; H Xu; S Zhou; D Wang; L Zhu; J Hou; J Tang; J Zhao; S Zhong
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

3.  Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Authors:  C Martin Tammemagi; Paul F Pinsky; Neil E Caporaso; Paul A Kvale; William G Hocking; Timothy R Church; Thomas L Riley; John Commins; Martin M Oken; Christine D Berg; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2011-05-23       Impact factor: 13.506

4.  Body mass index change in adulthood and lung and upper aerodigestive tract cancers.

Authors:  Heather P Tarleton; Sungshim Lani Park; Wei-Ming Zhu; Yuan-Chin Amy Lee; Mia Hashibe; Hal Morgenstern; Donald P Tashkin; Jenny T Mao; Wendy Cozen; Thomas M Mack; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2012-02-09       Impact factor: 7.396

5.  Body mass index and lung cancer risk in never smokers: a meta-analysis.

Authors:  Hongjun Zhu; Shuanglin Zhang
Journal:  BMC Cancer       Date:  2018-06-05       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.